XtalPi Holdings Limited (2228.HK)
Uses AI and automation to speed up drug discovery and chemical synthesis for pharmaceutical companies.
6.79-0.05%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+19.1%
The outlook
XtalPi (2228.HK) trades at 6.79 with strong analyst buy ratings, though the stock sits well below its moving averages and near the low end of its 52-week range. The average analyst price target is roughly 56% above the current level, but the elevated trailing P/E of 226 reflects significant valuation expectations. The overall technical picture shows weakness despite bullish analyst sentiment.
What’s behind the score
Analyst consensusStrong Buy — 1.4 avg of 5 analysts
Price trendBelow its 50- & 200-day averages
52-week range12% of the way from its 52-week low to high
Price targetAvg target +56% vs current price
Analyst price target
~12-month · 5 analysts10.58average target+55.8% vs now
Now 6.79
Low 8.00High 12.10
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$29.22B
52-wk high
15.12
52-wk low
5.67
50-day avg
7.49
200-day avg
9.71
Trailing P/E
226.3